Augmentin (Amoxicillin/Clavulanate): Indications and Dosing
Augmentin (amoxicillin/clavulanate) is indicated for respiratory tract infections, skin and soft tissue infections, urinary tract infections, and intra-abdominal infections, with dosing based on infection severity, patient age, and weight.
Adult Indications and Dosing
Standard Adult Dosing Options:
- Mild to Moderate Infections:
- 500 mg/125 mg orally every 8 hours OR
- 875 mg/125 mg orally every 12 hours 1
Specific Adult Indications:
Respiratory Tract Infections
- Community-acquired pneumonia, sinusitis, bronchitis:
- 875 mg/125 mg orally every 12 hours OR
- 500 mg/125 mg orally every 8 hours 1
Aspiration Pneumonia
- Outpatient treatment:
- 875 mg/125 mg orally every 12 hours OR
- 500 mg/125 mg orally every 8 hours 2
- Inpatient treatment:
- 1.2 g IV every 8 hours 2
Urinary Tract Infections
- Uncomplicated UTI:
- Complicated UTI:
Intra-abdominal Infections
- Mild to moderate with adequate source control:
- 2 g/0.2 g IV every 8 hours (immunocompetent patients) 3
- Severe or immunocompromised:
- 4 g/0.5 g every 6 hours or 16 g/2 g by continuous infusion 3
Pediatric Indications and Dosing
Age-Based Dosing:
Neonates and infants <12 weeks:
Children ≥12 weeks (3 months) to <40 kg:
Children ≥40 kg:
- Use adult dosing recommendations 1
High-Dose Formulations
For Drug-Resistant Pathogens:
- Adults:
- 2000 mg/125 mg (Augmentin XR) orally twice daily for respiratory infections with drug-resistant pathogens 6
- Children:
- 90 mg/6.4 mg/kg/day in two divided doses (Augmentin ES-600) for persistent/recurrent otitis media 6
Important Clinical Considerations
Administration:
- Take at the start of a meal to enhance clavulanate absorption and minimize gastrointestinal intolerance 1
- Twice daily dosing improves compliance and has equivalent efficacy to three times daily dosing 7
Duration of Therapy:
- Respiratory infections: 5-7 days 2
- Aspiration pneumonia: 5-7 days, until patient is afebrile for 48-72 hours 2
- Acute otitis media: 10 days 1
- Intra-abdominal infections: 4 days in immunocompetent patients with adequate source control; up to 7 days in immunocompromised or critically ill patients 3
Formulation Notes:
- Two 250 mg/125 mg tablets should NOT be substituted for one 500 mg/125 mg tablet due to different clavulanate content 1
- 250 mg/125 mg tablet and 250 mg/62.5 mg chewable tablet are NOT interchangeable 1
Antimicrobial Spectrum:
- Effective against beta-lactamase-producing H. influenzae and M. catarrhalis 6
- Active against many strains of S. pneumoniae, including some with reduced penicillin susceptibility 6
- Covers many common pathogens in community-acquired infections 6, 5
Augmentin remains a cornerstone antibiotic for community-acquired infections, with formulations designed to address the increasing prevalence of resistant pathogens while maintaining a favorable safety profile.